Ori­gi­nal-Re­se­arch: PFISTERER Hol­ding SE (by GBC AG): BUY

Re­se­arch | 20 No­vem­ber 2025 14:30

Ori­gi­nal-Re­se­arch: PFISTERER Hol­ding SE – from GBC AG

20.11.2025 / 14:30 CET/CEST
Dis­se­mi­na­ti­on of a Re­se­arch, trans­mit­ted by EQS News – a ser­vice of EQS Group.
The is­suer is so­le­ly re­spon­si­ble for the con­tent of this re­se­arch. The re­sult of this re­se­arch does not con­sti­tu­te in­vest­ment ad­vice or an in­vi­ta­ti­on to con­clude cer­tain stock ex­ch­an­ge tran­sac­tions.


Clas­si­fi­ca­ti­on of GBC AG to PFISTERER Hol­ding SE

Com­pa­ny Name: PFISTERER Hol­ding SE
ISIN: DE000PFSE212
Re­ason for the re­se­arch: Re­se­arch stu­dy (Up­date)
Re­com­men­da­ti­on: Buy
Tar­get pri­ce: €85.00
Last ra­ting ch­an­ge:
Ana­lyst: Cos­min Fil­ker, Mar­cel Gold­mann

9‑month fi­gu­res ex­ceed our ex­pec­ta­ti­ons; fo­re­casts and tar­get pri­ce rai­sed

Af­ter PFISTERER was still af­fec­ted by the re­lo­ca­ti­on of the Wun­sie­del site to Ka­daň at the be­gin­ning of the year, it em­bark­ed on an im­pres­si­ve growth cour­se from the se­cond quar­ter of 2025 on­wards. This con­tin­ued in the third quar­ter of 2025 with a 25.5% in­crease in sa­les, brin­ging sa­les af­ter nine months to €326.63 mil­li­on, up 14.5% on the pre­vious ye­ar’s fi­gu­re of €285.16 mil­li­on.

In line with the si­gni­fi­cant in­crease in sa­les, PFISTERER shows no­ti­ceable im­pro­ve­ments at all ear­nings le­vels. Gross pro­fit in­creased to €135.36 mil­li­on in the first th­ree quar­ters of 2025 (pre­vious year: €110.77 mil­li­on), which cor­re­sponds to an in­crease in the gross mar­gin to 41.4% (pre­vious year: 38.8%). The po­si­ti­ve busi­ness de­ve­lo­p­ment in the OHL seg­ment, whe­re the gross mar­gin im­pro­ved si­gni­fi­cant­ly to 40.9% (pre­vious year: 31.9%), play­ed a par­ti­cu­lar­ly im­portant role in this.

De­spi­te the si­gni­fi­cant cost in­crea­ses as­so­cia­ted with the IPO in the se­cond quar­ter of 2025, the in­crease in ear­nings con­tin­ued at the EBITDA le­vel. In the first nine months of 2025, this rose by 30.3% to €57.84 mil­li­on (pre­vious year: €44.40 mil­li­on). This in­cludes, for ex­am­p­le, the hig­her con­sul­ting, IT and per­son­nel cos­ts as­so­cia­ted with the IPO, which si­gni­fi­cant­ly in­creased ad­mi­nis­tra­ti­ve ex­pen­ses to €28.66 mil­li­on (pre­vious year: €23.13 mil­li­on).

In its nine-month re­port, PFISTERER did not pu­blish any spe­ci­fic sa­les or ear­nings fo­re­casts for the cur­rent 2025 fi­nan­cial year. Ac­cor­ding to the com­pa­ny, it ex­pects the po­si­ti­ve trend in or­der in­ta­ke and sa­les to con­ti­nue. In the me­di­um term, the ad­jus­ted EBITDA mar­gin, which should gra­du­al­ly ap­proach EBITDA ‚as re­por­ted‘, is ex­pec­ted to be in the up­per ran­ge of the high teens mar­gin cor­ri­dor. A key ar­gu­ment for the ex­pec­ted con­ti­nua­tion of the po­si­ti­ve busi­ness de­ve­lo­p­ment is the si­gni­fi­cant ex­pan­si­on of the or­der back­log by 46.0% to €338.74 mil­li­on (pre­vious year: €231.96 mil­li­on). At €431.27 mil­li­on (pre­vious year: €322.84 mil­li­on), or­der in­ta­ke for the first nine months was up 33.6% on the pre­vious year.

If the trend seen in the first nine months of 2025 con­ti­nues, we esti­ma­te that the com­pa­ny will ge­ne­ra­te re­ve­nue growth of 15.1% to €440.86 mil­li­on (pre­vious GBC fo­re­cast: €427.37 mil­li­on). In terms of ear­nings, too, the per­for­mance in the first nine months ex­cee­ded our ori­gi­nal ex­pec­ta­ti­ons. We are the­r­e­fo­re rai­sing our EBITDA fo­re­cast to €78.00 mil­li­on (pre­vious GBC fo­re­cast: €72.37 mil­li­on). The EBITDA mar­gin would then be 17.7% (pre­vious GBC fo­re­cast: 16.9%), which would cor­re­spond exact­ly to the fi­gu­re al­re­a­dy achie­ved af­ter nine months in 2025. The same ap­pli­es to the sub­se­quent ear­nings le­vels. Ba­sed on our ad­jus­ted esti­ma­tes for 2025, we are also ma­king slight ad­jus­t­ments to our esti­ma­tes for the co­ming 2026 fi­nan­cial year. The me­di­um-term fo­re­casts (2027–2030) re­main un­ch­an­ged from our last re­se­arch stu­dy.

The ad­jus­t­ment of esti­ma­tes for the 2025 and 2026 fi­nan­cial ye­ars, the roll-over ef­fect and, in par­ti­cu­lar, the use of the mar­ket ap­proach in de­ter­mi­ning beta have a si­gni­fi­cant im­pact on the re­sult of the DCF va­lua­ti­on mo­del. The new mo­del re­sult is €85.00 per share (pre­vious­ly: €48.00) and we con­ti­nue to as­sign a ‚BUY‘ ra­ting.

You can down­load the re­se­arch here: 20251119_PFISTERER_Update_engl

Cont­act for ques­ti­ons:
GBC AG
Hal­der­stras­se 27
86150 Augs­burg
0821241133 0
research@​gbc-​ag.​de
++++++++++++++++
Of­fen­le­gung mög­li­cher In­ter­es­sens­kon­flik­te nach § 85 WpHG und Art. 20 MAR Beim oben ana­ly­sier­ten Un­ter­neh­men ist fol­gen­der mög­li­cher In­ter­es­sen­kon­flikt ge­ge­ben: (5a,11); Ei­nen Ka­ta­log mög­li­cher In­ter­es­sen­kon­flik­te fin­den Sie un­ter:
https://​www​.gbc​-ag​.de/​d​e​/​O​f​f​e​n​l​e​g​ung
+++++++++++++++
Com­ple­ti­on: 19.11.2025 (4:59 pm)
First dis­clo­sure: 19.11.2025 (5:30 pm)

GBC AG
Hal­der­stra­ße 27
86150 Augs­burg

Te­le­fon: +49 821 241133–0
E‑mail: office(@)gbc-ag.de

Fol­low us!